Laxatives Market Research Report - Global Forecast till 2027

Global Laxatives Market Research Report: Information by Drug Type (Hyperosmotic and Bulk-Forming), Route of Administration (Oral and Rectal), Indication (Chronic Constipation and Irritable Bowel Syndrome), End User (Hospitals & Clinics, Research Institutes and others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/2055-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2019- 2025 to 2020-2027. Cordially fill Sample form for updated data.

Market Scenario


Laxatives Market is expected to grow significantly over the forecast period. The global laxatives market was valued at approximately USD 5,574.6 million in 2017 and is projected to grow with a 5.9% CAGR over the forecast period.


A laxative is a type of medicine used to treat constipation, irritable bowel syndrome, and gastric problem.  This drug contains a chemical that helps in stool softening and increases stool mobility by relieving temporary constipation.


The key factors driving the market growth are increasing sedentary lifestyle, lack of exercise, diet-related factors such as eating unhealthy and junk food. Moreover, the higher prevalence of constipation in the geriatric population also boosts the laxatives market.


However, factors such as side effects associated with the drug and the presence of alternative medications are expected to hamper the market growth. 


Segmentation


The global laxatives market has been segmented into drug type, route of administration, indication, end users, and region.


Based on drug type, the global market has been segmented into hyperosmotic, bulk-forming, stool softeners, lubricants, stimulants, and others.


Based on route of administration, the global market has been divided into oral and rectal.


Based on indication, the global laxatives market has been segmented into chronic constipation, irritable bowel syndrome, and others.


The global market, by end user, has been segmented into hospitals & clinics, research institutes, and others.


The global laxative market, by region, has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The laxatives market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.  


The European laxatives market has been segmented into Western Europe and Eastern Europe. Western Europe has segmented into the UK, Germany, France, Spain, Italy, and the rest of Western Europe. 


The Asia-Pacific laxatives market has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.


The laxatives market in the Middle East & Africa has been segmented into the Middle East and Africa. The increasing development in healthcare infrastructure and the growing economy in countries such as Kuwait, Iran, Israel, and Iraq drive the market growth in this region.  


Key Players


Bayer AG (Germany), Boehringer Ingelheim Pharmaceuticals Inc. (Germany), Eskag Pharma Pvt. Ltd. (India), GlaxoSmithKline Plc (UK), Procter & Gamble Company (US), Purdue Pharma L.P.(US), Mallinckrodt Pharmaceuticals (UK) , Abbott Laboratories (US) , Braintree (US), AstraZeneca plc (UK), Sucampo Pharmaceuticals (US) are some of the key players operating in the global laxatives market.


Regional Market Summary


Global Laxatives Market Share (%), by Region, 2018


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, and Annual Reports


Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are anticipated to dominate the global laxatives market owing to the sedentary lifestyle and diet-related factors, such as not drinking enough water and high consumption of junk food, drive the laxatives market in this region. According to the Centers for Disease Control and Prevention 2017, 30.8 million suffered from digestive problems in the US.


Europe is expected to hold the second-largest position in the global laxatives market. The presence of a large patient population suffering from the intestinal problem and sedentary lifestyles are driving the laxative market growth in this region. Furthermore, the presence of large number of healthcare companies in this region drives market growth.


Asia-Pacific is expected to be the fastest-growing region owing to the growing geriatric population with digestive problems. Additionally, the change in routine and consumption of medicines such as


antidepressants, calcium channel blocking drugs, opioids, and hydromorphone, among others can cause digestive problems and increases the demand for laxatives in the region.


The Middle East & Africa is expected to hold the least share of the market during the forecast period. A majority of the market share of this region is expected to be held by the Middle East due to the growing government initiatives for the healthcare sector in this region.


Global Durable Medical Equipment Market, by Drug Type



  • Hyperosmotic

  • Bulk-Forming

  • Stool Softeners

  • Lubricants

  • Stimulants

  • Others


Global Durable Medical Equipment Market, by Route of Administration



  • Oral

  • Rectal


Global Durable Medical Equipment Market, by Indication



  • Chronic Constipation

  • Irritable Bowel Syndrome

  • Others


Global Durable Medical Equipment Market, by End User



  • Hospitals & Clinics

  • Research Institutes

  • Others


Global Durable Medical Equipment Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Pharmaceutical manufacturing companies

  • Suppliers and distributors of medicines

  • Hospitals and diagnostic centers

  • Academic centers

  • Venture capitalists



Report Scope:
Report Attribute/Metric Details
  Market Size   2025: Significant Value
  CAGR   5.9% (2019-2025)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Drug Type, Route of Administration, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bayer AG (Germany), Boehringer Ingelheim Pharmaceuticals Inc. (Germany), Eskag Pharma Pvt. Ltd. (India), GlaxoSmithKline Plc (UK), Procter & Gamble Company (US), Purdue Pharma L.P.(US), Mallinckrodt Pharmaceuticals (UK) , Abbott Laboratories (US) , Braintree (US), AstraZeneca plc (UK), Sucampo Pharmaceuticals (US)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing sedentary lifestyle.
  • The Higher prevalence of constipation in the geriatric population


  • Frequently Asked Questions (FAQ) :


    Global Laxatives Market is projected to grow at a 5% CAGR between 2017-2022.

    North America is predicted to dominate the Laxatives Market.

    Different end use industries of Laxatives Market include research institutes and hospitals & clinics.

    Lack of exercise and increasing sedentary lifestyle are adding market growth.

    Presence of alternatives and some side effects may limit market growth.

    Please note that the assessment period of report has been updated from 2013- 2022 to 2020-2027. Cordially fill Sample form for updated data.

    Table of Contents

    1. REPORT PROLOGUE

    2. MARKET INTRODUCTION

    2.1. Definition

    2.2. Scope of the Study

    2.2.1. Research Objective

    2.2.2. Assumptions

    2.2.3. Limitations

    3. RESEARCH METHODOLOGY

    3.1. Overview

    3.2. Primary Research

    3.3. Secondary Research

    3.4. Market Size Estimation

    4. MARKET DYNAMICS

    4.1. Overview

    4.2. Drivers

    4.3. Restraints

    4.4. Opportunities

    5. MARKET FACTOR ANALYSIS

    5.1. Porter’s Five Forces Analysis

    5.1.1. Bargaining Power of Suppliers

    5.1.2. Bargaining Power of Buyers

    5.1.3. Threat of New Entrants

    5.1.4. Threat of Substitutes

    5.1.5. Intensity of Rivalry

    5.2. Value Chain Analysis


    6. GLOBAL LAXATIVES MARKET, BY DRUG TYPE

    6.1. Overview

    6.2. Hyperosmotic

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3. Bulk-Forming

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4. Stool Softeners

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.5. Lubricants

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.6. Stimulants

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.7. Other

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7. GLOBAL LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION

    7.1. Overview

    7.2. Oral

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3. Rectal

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8. GLOBAL LAXATIVES MARKET, BY INDICATION

    8.1. Overview

    8.2. Chronic Constipation

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3. Irritable Bowel Syndrome

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4. Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    GLOBAL LAXATIVES MARKET, BY END USER

    9.1. Overview

    9.2. Hospitals & Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3. Research Institutes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4. Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10. GLOBAL LAXATIVES MARKET, BY REGION

    10.1. Overview

    10.2. Americas

    10.2.1. North America

    10.2.1.1. US

    10.2.1.2. Canada

    10.2.2. Latin America

    10.3. Europe

    10.3.1. Western Europe

    10.3.1.1. Germany

    10.3.1.2. France

    10.3.1.3. Italy

    10.3.1.4. Spain

    10.3.1.5. UK

    10.3.1.6. Rest of Western Europe

    10.3.2. Eastern Europe

    10.4. Asia-Pacific

    10.4.1. Japan

    10.4.2. China

    10.4.3. India

    10.4.4. Australia

    10.4.5. South Korea

    10.4.6. Rest of Asia-Pacific

    10.5. Middle East & Africa

    10.5.1. Middle East

    10.5.2. Africa

    11. COMPANY LANDSCAPE

    11.1. Overview

    11.2. Competitive Analysis

    11.3. Market Share Analysis

    11.4. Major Growth Strategy in the Global Laxatives Market

    11.5. Competitive Benchmarking

    11.6. Leading Players in Terms of the Number of Developments in the Global Laxatives Market

    11.7. Key developments and Growth Strategies

    11.7.1. New Product Launch/Service Deployment

    11.7.2. Mergers and Acquisitions

    11.7.3. Joint Ventures

    11.8. Major Players Financial Matrix & Market Ratio

    11.8.1. Sales & Operating Income 2020

    11.8.2. Major Players R&D Expenditure 2020

    11.9. Major Players Capital Market Ratio

    12. COMPANY PROFILES

    12.1. Bayer AG

    12.1.1. Company Overview

    12.1.2. Product Overview

    12.1.3. Financial Overview

    12.1.4. Key Developments

    12.1.5. SWOT Analysis

    12.1.6. Key Strategies

    12.2. Boehringer Ingelheim Pharmaceuticals Inc.

    12.2.1. Company Overview

    12.2.2. Product Overview

    12.2.3. Financial Overview

    12.2.4. Key Developments

    12.2.5. SWOT Analysis

    12.2.6. Key Strategies

    12.3. Eskag Pharma Pvt. Ltd.

    12.3.1. Company Overview

    12.3.2. Product Overview

    12.3.3. Financial Overview

    12.3.4. Key Developments

    12.3.5. SWOT Analysis

    12.3.6. Key Strategies

    12.4. GlaxoSmithKline Plc

    12.4.1. Company Overview

    12.4.2. Product Overview

    12.4.3. Financial Overview

    12.4.4. Key Developments

    12.4.5. SWOT Analysis

    12.4.6. Key Strategies

    12.5. Procter & Gamble Company

    12.5.1. Company Overview

    12.5.2. Product Overview

    12.5.3. Financial Overview

    12.5.4. Key Developments

    12.5.5. SWOT Analysis

    12.5.6. Key Strategies

    12.6. Purdue Pharma L.P.

    12.6.1. Company Overview

    12.6.2. Product Overview

    12.6.3. Financial Overview

    12.6.4. Key Developments

    12.6.5. SWOT Analysis

    12.6.6. Key Strategies

    12.7. Mallinckrodt Pharmaceuticals

    12.7.1. Company Overview

    12.7.2. Product Overview

    12.7.3. Financial Overview

    12.7.4. Key Developments

    12.7.5. SWOT Analysis

    12.7.6. Key Strategies

    12.8. Abbott Laboratories

    12.8.1. Company Overview

    12.8.2. Product Overview

    12.8.3. Financial Overview

    12.8.4. Key Developments

    12.8.5. SWOT Analysis

    12.8.6. Key Strategies

    12.9. Braintree

    12.9.1. Company Overview

    12.9.2. Product Overview

    12.9.3. Financial Overview

    12.9.4. Key Developments

    12.9.5. SWOT Analysis

    12.9.6. Key Strategies

    12.10. Sucampo Pharmaceuticals

    12.10.1. Company Overview

    12.10.2. Product Overview

    12.10.3. Financial Overview

    12.10.4. Key Developments

    12.10.5. SWOT Analysis

    12.10.6. Key Strategies

    12.11. Others

    13. APPENDIX

    13.1. References

    13.2. Related Reports

    LIST OF TABLES

    TABLE 1 GLOBAL LAXATIVES MARKET SYNOPSIS, 2020-2027

    TABLE 2 GLOBAL LAXATIVES MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

    TABLE 3 GLOBAL LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 4 GLOBAL LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 5 GLOBAL LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 6 GLOBAL LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 7 GLOBAL LAXATIVES MARKET, BY REGION, 2020-2027 (USD MILLION)

    TABLE 8 NORTH AMERICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 9 NORTH AMERICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 10 NORTH AMERICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 11 NORTH AMERICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 12 US: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 13 US: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 14 US: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 15 US: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 16 CANADA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 17 CANADA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 18 CANADA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 19 CANADA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 20 LATIN AMERICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 21 LATIN AMERICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 22 LATIN AMERICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 23 LATIN AMERICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 24 EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 25 EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 26 EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 27 EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 28 WESTERN EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 29 WESTERN EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 30 WESTERN EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 31 WESTERN EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 32 EASTERN EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 33 EASTERN EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 34 EASTERN EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 35 EASTERN EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 36 ASIA-PACIFIC: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 37 ASIA-PACIFIC: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 38 ASIA-PACIFIC: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 39 ASIA-PACIFIC: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 40 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

    TABLE 41 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

    TABLE 42 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

    TABLE 43 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)


    LIST OF FIGURES

    FIGURE 1 RESEARCH PROCESS

    FIGURE 2 MARKET STRUCTURE OF THE GLOBAL LAXATIVES MARKET

    FIGURE 3 MARKET DYNAMICS OF THE GLOBAL LAXATIVES MARKET

    FIGURE 4 GLOBAL LAXATIVES MARKET SHARE, BY DRUG TYPE, 2020 (%)

    FIGURE 5 GLOBAL LAXATIVES MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2020 (%)

    FIGURE 6 GLOBAL LAXATIVES MARKET SHARE, BY INDICATION, 2020 (%)

    FIGURE 7 GLOBAL LAXATIVES MARKET SHARE, BY END USER, 2020 (%)

    FIGURE 8 GLOBAL LAXATIVES MARKET SHARE, BY REGION, 2020 (%)

    FIGURE 7 AMERICAS: LAXATIVES MARKET SHARE BY REGION, 2020 (%)

    FIGURE 9 NORTH AMERICA: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 10 EUROPE: LAXATIVES MARKET SHARE, BY REGION, 2020 (%)

    FIGURE 11 WESTERN EUROPE: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 12 ASIA-PACIFIC: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 13 MIDDLE EAST & AFRICA: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 14 GLOBAL LAXATIVES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

    FIGURE 15 BAYER AG.: KEY FINANCIALS

    FIGURE 16 BAYER AG: SEGMENTAL REVENUE

    FIGURE 17 BAYER AG: REGIONAL REVENUE

    FIGURE 18 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: KEY FINANCIALS

    FIGURE 19 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: SEGMENTAL REVENUE

    FIGURE 20 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: REGIONAL REVENUE

    FIGURE 21 ESKAG PHARMA PVT. LTD.: KEY FINANCIALS

    FIGURE 22 ESKAG PHARMA PVT. LTD.: SEGMENTAL REVENUE

    FIGURE 23 ESKAG PHARMA PVT. LTD.: REGIONAL REVENUE

    FIGURE 24 GLAXOSMITHKLINE PLC: KEY FINANCIALS

    FIGURE 25 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

    FIGURE 26 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

    FIGURE 27 PROCTER & GAMBLE COMPANY: KEY FINANCIALS

    FIGURE 28 PROCTER & GAMBLE COMPANY: SEGMENTAL REVENUE

    FIGURE 29 PROCTER & GAMBLE COMPANY: REGIONAL REVENUE

    FIGURE 30 PURDUE PHARMA L.P.: KEY FINANCIALS

    FIGURE 31 PURDUE PHARMA L.P.: SEGMENTAL REVENUE

    FIGURE 32 PURDUE PHARMA L.P.: REGIONAL REVENUE

    FIGURE 33 MALLINCKRODT PHARMACEUTICALS: KEY FINANCIALS

    FIGURE 34 MALLINCKRODT PHARMACEUTICALS: SEGMENTAL REVENUE

    FIGURE 35 MALLINCKRODT PHARMACEUTICALS: REGIONAL REVENUE

    FIGURE 36 ABBOTT LABORATORIES: KEY FINANCIALS

    FIGURE 37 ABBOTT LABORATORIES: SEGMENTAL REVENUE

    FIGURE 38 ABBOTT LABORATORIES: REGIONAL REVENUE

    FIGURE 39 BRAINTREE: KEY FINANCIALS

    FIGURE 40 BRAINTREE: SEGMENTAL REVENUE

    FIGURE 41 BRAINTREE: REGIONAL REVENUE

    FIGURE 42 SUCAMPO PHARMACEUTICALS: KEY FINANCIALS

    FIGURE 43 SUCAMPO PHARMACEUTICALS: SEGMENTAL REVENUE

    FIGURE 44 SUCAMPO PHARMACEUTICALS: REGIONAL REVENUE